Related Experiment Video
Updated: Apr 27, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Immunoglobulin G4-related Retroperitoneal Fibrosis of the Pelvis
Anthony Dyer1, Peter M Sadow2, Erika Bracamonte3
1Division of Urology, Department of Surgery, The University of Arizona, Tucson, AZ.
Abstract:
Retroperitoneal fibrosis (RPF) is a rare disease characterized by the replacement of normal tissue with fibrosis and/or inflammation. In this case, a 68-year-old man presented with RPF in the pelvis, a rare location for this disease. Biopsies were performed, which showed elevated levels of C-reactive protein, erythrocyte sedimentation rate, and, most importantly, immunoglobulin G4 (IgG4). It has been postulated that IgG4-related sclerosing disease is a systemic disease. Treatment has been successful with systemic corticosteroids.
Insights
Retroperitoneal fibrosis (RPF), a rare condition causing tissue scarring, can occur in the pelvis. This case highlights successful treatment of pelvic RPF with immunoglobulin G4 (IgG4) elevation using corticosteroids.
Area of Science:
- Urology
- Immunology
- Pathology
Background:
- Retroperitoneal fibrosis (RPF) is a rare condition involving tissue replacement by fibrosis and inflammation.
- RPF typically affects the retroperitoneum but can present in unusual locations.
- Immunoglobulin G4-related disease (IgG4-RD) is increasingly recognized as a systemic condition.
Purpose of the Study:
- To report a rare case of pelvic retroperitoneal fibrosis.
- To discuss the diagnostic findings, including elevated immunoglobulin G4 (IgG4) levels.
- To highlight successful treatment outcomes for this presentation.
Main Methods:
- Clinical presentation of a 68-year-old male patient with pelvic RPF.
- Diagnostic workup including laboratory tests (CRP, ESR, IgG4).
- Histopathological examination of biopsy samples.
Main Results:
- Biopsy confirmed RPF in the pelvic region.
- Elevated levels of C-reactive protein, erythrocyte sedimentation rate, and immunoglobulin G4 (IgG4) were observed.
- The patient responded well to systemic corticosteroid therapy.
Conclusions:
- Pelvic RPF is an uncommon manifestation of retroperitoneal fibrosis.
- Elevated IgG4 levels suggest a potential link to IgG4-related sclerosing disease.
- Systemic corticosteroids are an effective treatment for this condition.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Nephrotic Syndrome I : Introduction

